These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38065243)

  • 21. Near-infrared spectroscopic applications in pharmaceutical particle technology.
    Razuc M; Grafia A; Gallo L; Ramírez-Rigo MV; Romañach RJ
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1565-1589. PubMed ID: 31282753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between integrated continuous direct compression line and batch processing - The effect of raw material properties.
    Karttunen AP; Wikström H; Tajarobi P; Fransson M; Sparén A; Marucci M; Ketolainen J; Folestad S; Korhonen O; Abrahmsén-Alami S
    Eur J Pharm Sci; 2019 May; 133():40-53. PubMed ID: 30862514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
    Hasanain F; Guenther K; Mullett WM; Craven E
    PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards integrated drug substance and drug product design for an active pharmaceutical ingredient using particle engineering.
    Kougoulos E; Smales I; Verrier HM
    AAPS PharmSciTech; 2011 Mar; 12(1):287-94. PubMed ID: 21246419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of Drug-Excipient Particle Attributes with Droplet Microfluidic-based Extractive Solidification Enables Improved Powder Rheology.
    Ng DZL; Nelson AZ; Ward G; Lai D; Doyle PS; Khan SA
    Pharm Res; 2022 Feb; 39(2):411-421. PubMed ID: 35119593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation.
    Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M
    Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.
    Cole KP; Johnson MD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):5-13. PubMed ID: 29206489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
    Mangal S; Meiser F; Morton D; Larson I
    Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
    J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Relevance of Crystal Forms in the Pharmaceutical Field: Sword of Damocles or Innovation Tools?
    Braga D; Casali L; Grepioni F
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A continuous manufacturing concept for a pharmaceutical oral suspension.
    Bostijn N; Van Renterghem J; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2018 Oct; 123():576-583. PubMed ID: 30102980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical co-crystals-an opportunity for drug product enhancement.
    Miroshnyk I; Mirza S; Sandler N
    Expert Opin Drug Deliv; 2009 Apr; 6(4):333-41. PubMed ID: 19348603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Quantitative X-ray Microscopy for Assessment of API and Excipient Microstructure Evolution in Solid Dosage Processing.
    Zhu A; Mao C; Luner PE; Lomeo J; So C; Marchal S; Zhang S
    AAPS PharmSciTech; 2022 Apr; 23(5):117. PubMed ID: 35441297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.